Benzinga | Jan 26, 2022 08:55AM EST

Macquarie Upgrades UiPath to Outperform, Lowers Price Target to $47

Macquarie analyst Frederick Havemeyer upgrades UiPath (NYSE:PATH) from Neutral to Outperform and lowers the price target from $55 to $47.